[Federal Register: September 26, 2001 (Volume 66, Number 187)]
[Notices]               
[Page 49195]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26se01-73]                         


[[Page 49195]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 19(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, SCOR Molecular Medicine and Atherosclerosis.
    Date: October 24-26, 2001.
    Time: 7 pm to 5 pm.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn--Chevy Chase, 5520 Wisconsin Avenue, 
Bethesda, MD 20815.
    Contact Person: William J. Johnson, PhD, NIH/NHLBI/DEA/Review 
Branch, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20892-9692, 
301-435-0277.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: September 18, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-24030 Filed 9-25-01; 8:45 am]
BILLING CODE 4140-01-M